Navigation Links
Angiotech announces director resignation
Date:4/15/2008

VANCOUVER, April 15 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, announced the resignation of Greg Peet from his position as a non-executive director of the Company. Mr. Peet has resigned to enable him to focus on his numerous business pursuits and additional board appointments. Mr. Peet has served on Angiotech's Board of Directors since 2005. This position will not be replaced at the current time and the remaining six directors will continue to carry out the duties of the board.

"The board and management would like to thank Greg for his many contributions to the Company's development," said David Howard, Angiotech's Chairman of the Board. "We wish him well in his future endeavours."

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at http://www.angiotech.com.

CONTACT: Deirdre Neary, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
2. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference
3. 960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotechs Novel 5-FU Central Venous Catheter
4. Angiotech to participate in Lehman Brothers Healthcare Conference
5. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
6. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
7. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
8. Angiotech announces results for the fourth quarter ended December 31, 2007
9. Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
11. Angiotech and Symphony Medical Announce Licensing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... RESEARCH TRIANGLE PARK, N.C. , April 27, 2017 ... ) today announced that its Board of Directors authorized ... company,s common stock. This program will became effective immediately, ... may be made in the open market, accelerated share ... time as determined by United Therapeutics, management and in ...
(Date:4/27/2017)... ... April 27, 2017 , ... Oncolinx, a ... 43North Startup Competition, has truly taken their cancer research out of this world. ... experiments from Cape Canaveral to the International Space Station’s (ISS) U.S. National Laboratory, ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... provider for digital pathology, today announced their digital pathology technology has the potential ... provided by five medical centers in The Netherlands as part of the ...
(Date:4/27/2017)... ... 27, 2017 , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, ... LHON is a rare devastating genetic disease that leads to a sudden and rapid ... of 20 patients carrying 11778, 14484 and 3460 mutations and having experienced the onset ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/19/2017)... York , April 19, 2017 ... as its vendor landscape is marked by the presence ... market is however held by five major players - ... Together these companies accounted for nearly 61% of the ... the leading companies in the global military biometrics market ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
Breaking Biology News(10 mins):